Renato Porto
An executive with over 20 years' experience in regulated markets. He has been the CEO of Interfarma (the Brazilian Pharmaceutical Research Industry Association) since 2023.
Previously, he was a director at the National Health Surveillance Agency (Anvisa) and at the Brazilian Association of Pharmacy and Drugstore Networks (Abrafarma), where he was responsible for institutional relations.
He holds a law degree from UniCEUB and has specialised in Health Surveillance (Fiocruz), Civil Procedural Law (PUC-SP) and Health Management (MBA, FGV). He has also completed Board Member training with IBGC and received international training in Regulatory Impact Analysis at LUISS Guido Carli University in Italy.